Assessing The Future Of Robotics In Medtech
Executive Summary
Andy Kach, a principal in ZS's Medical Products and Services practice, offers his perspective on the “war of the robots” in the surgical technology market. He argues that companies that focus on specialized, expensive technologies will eventually cede market share to systems that are multifunctional, portable, and valuable to multiple surgical departments.
You may also be interested in...
Rising Procedure Volumes Push Intuitive Surgical Third-Quarter Earnings Above Forecast
Intuitive Surgical reported higher-than-expected third-quarter revenues with strong procedure growth and ongoing adoption of the da Vinci system in the US and outside of the US.
Mako Robot Sales Drive Stryker’s Orthopedics Business In Second Quarter
Stryker reported organic growth of 8.5% during the second quarter of 2019 led by 12% growth in the medical and surgical equipment business, 7% growth in neurotechnology and spine revenue, and 6% growth in sales of orthopedic devices, led by the Mako robotic surgery system.
Zimmer Biomet Continues Turnaround Lead by ROSA Robot
Zimmer Biomet’s net sales were up 1.2% year-over-year in the second quarter. CEO Bryan Hanson said the ROSA Knee robotic surgery system is performing even better than expected since it launched earlier this year, and is expected to be an important revenue-driver in the future.